Winmark (NASDAQ: WINA) director granted 356 stock options at $378.57
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
WINMARK CORP director Amy C. Becker reported a new stock option grant and updated her existing option holdings. On 2026-06-01, she received a non-employee stock option covering 356 shares of common stock at an exercise price of $378.57 per share. The option becomes exercisable starting 2027-06-01 and expires on 2036-06-01, and a footnote states it vests 25% per year for four years.
The filing also lists previously granted non-employee stock options she continues to hold, including grants exercisable at $248.64 for 5,500 underlying shares expiring on 2032-11-15, and at $238.60 for 620 underlying shares expiring on 2032-12-12. The transactions disclosed are compensation-related option awards and holdings, with no open‑market purchases or sales of common stock reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
Becker Amy C
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Employee Stock Option (right to buy) | 356 | $378.57 | $135K |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Non-Employee Stock Option (right to buy) — 356 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
New option grant: 356 options
New option exercise price: $378.57 per share
New option expiration: 2036-06-01
+4 more
7 metrics
New option grant
356 options
Non-employee stock option granted on 2026-06-01
New option exercise price
$378.57 per share
Exercise price for 356-share option grant
New option expiration
2036-06-01
Expiration date of new option grant
Large prior grant
5,500 options
Underlying shares at $248.64, expiring 2032-11-15
Prior grant exercise price
$248.64 per share
Exercise price for 5,500-share option grant
Additional prior grant
620 options
Underlying shares at $238.60, expiring 2032-12-12
Additional grant exercise price
$238.60 per share
Exercise price for 620-share option grant
Key Terms
Non-Employee Stock Option (right to buy), exercise price, expiration date, underlying security shares, +1 more
5 terms
Non-Employee Stock Option (right to buy) financial
"Security title is listed as Non-Employee Stock Option (right to buy)."
exercise price financial
"Conversion or exercise price values such as 378.5700 and 248.6400 are disclosed."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"Each option grant includes an expiration date, for example 2036-06-01 and 2032-11-15."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Grant, award, or other acquisition financial
"The transaction code description for the new option is Grant, award, or other acquisition."
FAQ
What did WINMARK CORP (WINA) director Amy C. Becker report in this Form 4?
Amy C. Becker reported a new non-employee stock option grant and updated her option holdings. The filing shows a 356-share option award plus several previously granted options that remain outstanding with different exercise prices and expiration dates.
How many WINMARK CORP options were granted to Amy C. Becker and at what price?
She was granted options on 356 shares of WINMARK CORP common stock at an exercise price of $378.57 per share. These options are classified as a non-employee stock option (right to buy) and represent a compensation-related award.
When do Amy C. Becker’s newly granted WINMARK CORP options vest and expire?
The new options begin to be exercisable on June 1, 2027 and expire on June 1, 2036. A footnote explains they vest 25% per year for four years, typical for time-based director compensation grants.
Does this WINMARK CORP Form 4 show any stock being bought or sold on the market?
No open-market purchases or sales are reported. The Form 4 shows a grant of non-employee stock options and multiple option holdings. All transactions relate to derivative securities rather than direct trading of WINMARK common shares.
What other WINMARK CORP option grants does Amy C. Becker hold according to this filing?
She holds several prior non-employee stock option grants, including options exercisable at $248.64 for 5,500 underlying shares and at $238.60 for 620 underlying shares. These options have expiration dates in 2032 and remain outstanding.
Is Amy C. Becker’s Form 4 activity a routine director compensation event for WINMARK CORP?
The filing describes a grant classified as a non-employee stock option with vesting of 25% per year for four years. This pattern is consistent with routine director equity compensation rather than discretionary open‑market trading activity.